|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.070 CNY | -2.54% |
|
-1.29% | -22.86% |
| Market Cap | 2.41B 354M 311M 287M 268M 503M 33.44B 512M 3.44B 1.33B 16.48B 1.33B 1.3B 57.28B | P/E 2024 |
-8.86x | P/E 2025 | -9.48x |
|---|---|---|---|---|---|
| Enterprise Value | 2.63B 386M 339M 313M 292M 548M 36.45B 558M 3.75B 1.45B 17.97B 1.45B 1.42B 62.44B | EV / Sales 2024 |
1.48x | EV / Sales 2025 | 1.79x |
| Free-Float |
67.99% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.54% | ||
| 1 week | -1.29% | ||
| Current month | -13.28% | ||
| 1 month | -17.03% | ||
| 3 months | -17.47% | ||
| 6 months | -26.02% | ||
| Current year | -22.86% |
| 1 week | 2.96 |  | 3.38 |
| 1 month | 2.96 | | 3.67 |
| Current year | 2.96 | | 5.27 |
| 1 year | 2.96 | | 5.27 |
| 3 years | 2.76 | | 6.15 |
| 5 years | 2.76 | | 8.8 |
| 10 years | 2.76 | | 20.3 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Qi Dou
CEO | Chief Executive Officer | 42 | 13/05/2021 |
Xianti Zeng
DFI | Director of Finance/CFO | 52 | 06/09/2024 |
Zhi Wei Wang
PRN | Corporate Officer/Principal | 56 | 17/09/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Qi Ling Dou
CHM | Chairman | 66 | 22/01/2009 |
Zhi Wei Wang
BRD | Director/Board Member | 56 | 21/02/2011 |
Ya Qi Dou
BRD | Director/Board Member | 42 | 03/01/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -1.29% | -19.84% | -40.16% | 354M | |
| +0.93% | +2.65% | +42.33% | +145.77% | 1,006B | |
| +1.61% | +7.22% | +60.81% | +47.98% | 589B | |
| +3.51% | +12.31% | +31.15% | +78.88% | 430B | |
| -0.73% | +5.11% | +29.26% | +21.27% | 331B | |
| -0.28% | +6.01% | +38.31% | +24.25% | 288B | |
| -1.18% | +5.36% | +29.81% | +40.17% | 285B | |
| -1.99% | +5.73% | -28.12% | -42.37% | 213B | |
| +0.40% | +4.51% | +25.85% | +55.35% | 190B | |
| -1.05% | +0.06% | +16.91% | +59.86% | 154B | |
| Average | -0.15% | +5.23% | +22.65% | +39.10% | 348.61B | |
| Weighted average by Cap. | +0.62% | +5.38% | +35.15% | +70.26% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.17B 320M 281M 259M 242M 454M 30.19B 462M 3.11B 1.2B 14.88B 1.2B 1.17B 51.71B | 1.86B 274M 241M 222M 207M 389M 25.87B 396M 2.66B 1.03B 12.75B 1.03B 1.01B 44.31B |
| Net income | -317M -46.68M -41M -37.78M -35.32M -66.25M -4.4B -67.46M -453M -176M -2.17B -175M -171M -7.55B | -330M -48.49M -42.6M -39.25M -36.7M -68.82M -4.58B -70.09M -471M -182M -2.26B -182M -178M -7.84B |
| Net Debt | 411M 60.46M 53.11M 48.93M 45.75M 85.81M 5.7B 87.38M 587M 227M 2.81B 227M 222M 9.77B | 217M 31.95M 28.06M 25.85M 24.17M 45.34M 3.01B 46.17M 310M 120M 1.49B 120M 117M 5.16B |
Employees
4,832
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/06/26 | CN¥3.070 | -2.54% | 19,570,807 |
| 24/06/26 | CN¥3.150 | -3.67% | 26,558,600 |
| 23/06/26 | CN¥3.270 | +4.81% | 33,286,508 |
| 22/06/26 | CN¥3.120 | +0.32% | 20,616,923 |
| 18/06/26 | CN¥3.110 | -1.27% | 18,397,100 |
- Stock Market
- Stocks
- 600594 Stock
Select your edition
All financial news and data tailored to specific country editions
